Publications

Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.

Meng Q, Garcia-Rodriguez C, Manzanarez G, Silberg MA, Conrad F, Bettencourt J, Pan X, Breece T, To R, Li M, Lee D, Thorner L, Tomic MT, Marks JD

Analytical biochemistry
. Aug 21, 2012
N-Terminal labeling of filamentous phage to create cancer marker imaging agents.

Carrico ZM, Farkas ME, Zhou Y, Hsiao SC, Marks JD, Chokhawala H, Clark DS, Francis MB

ACS nano
. Aug 6, 2012
An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors.

McCabe KE, Liu B, Marks JD, Tomlinson JS, Wu H, Wu AM

Molecular imaging and biology
. Jun 1, 2012
Selection and characterization of cell binding and internalizing phage antibodies.

Zhou Y, Zhao L, Marks JD

Archives of biochemistry and biophysics
. May 22, 2012
Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.

Zhou Y, Goenaga AL, Harms BD, Zou H, Lou J, Conrad F, Adams GP, Schoeberl B, Nielsen UB, Marks JD

Molecular cancer therapeutics
. May 7, 2012
A functional dual-coated (FDC) microtiter plate method to replace the botulinum toxin LD50 test.

Liu YY, Rigsby P, Sesardic D, Marks JD, Jones RG

Analytical biochemistry
. Mar 6, 2012
Building and characterizing antibody-targeted lipidic nanotherapeutics.

Kirpotin DB, Noble CO, Hayes ME, Huang Z, Kornaga T, Zhou Y, Nielsen UB, Marks JD, Drummond DC

Methods in enzymology
. Jan 1, 2012
Discovery of internalizing antibodies to tumor antigens from phage libraries.

Zhou Y, Marks JD

Methods in enzymology
. Jan 1, 2012
Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity.

Cao Y, Marks JD, Huang Q, Rudnick SI, Xiong C, Hittelman WN, Wen X, Marks JW, Cheung LH, Boland K, Li C, Adams GP, Rosenblum MG

Molecular cancer therapeutics
. Nov 16, 2011
Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.

Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR

BMC biochemistry
. Nov 15, 2011